[1] QIN B D,WANG J Q,YANG Z X,et al.Epidemiology of primary sjögren's syndrome:a systematic review and meta-analysis[J].Ann Rheum Dis,2015,74(11):1983-1989.
[2] MARIETTE X,CRISWELL L A.Primary sjögren's syndrome[J].N Engl J Med,2018,378(10):931-939.
[3] NOCTURNE G,MARIETTE X.Advances in understanding the pathogenesis of primary sjogren's syndrome[J].Nat Rev Rheumatol,2013,9(9):544-556.
[4] 高雅静,庞春艳,王永福.干燥综合征相关自身抗体检测的研究进展[J].东南大学学报(医学版),2021,40(5):704-707.
[5] SHIBOSKI C H,SHIBOSKI S C,SEROR R,et al.2016 American College of Rheumatology/European League Against Rheumatism classification criteria for primary sjögren's syndrome:a consensus and data-driven methodology involving three international patient cohorts[J].Ann Rheum Dis,2017,76(1):9-16.
[6] THEANDER E,JONSSON R,SJÖSTRÖM B,et al.Prediction of sjögren's syndrome years before diagnosis and identification of patients with early onset and severe disease course by autoantibody profiling[J].Arthritis Rheumatol,2015,67(9):2427-2436.
[7] LANGFELDER P,HORVATH S.WGCNA:an R package for weighted correlation network analysis[J].BMC Bioinformatics,2008,29(9):559-570.
[8] JAMES K,AL-ALI S,TARN J,et al.A transcriptional signature of fatigue derived from patients with primary sjögren's syndrome[J].PLoS One,2015,10(12):e0143970.
[9] TASAKI S,SUZUKI K,NISHIKAWA A,et al.Multiomic disease signatures converge to cytotoxic CD8 T cells in primary Sjögren's syndrome[J].Ann Rheum Dis 2017,76(8):1458-1466.
[10] LESSARD C J,LI H,ADRIANTO I,et al.Variants at multiple loci implicated in both innate and adaptive immune responses are associated with sjögren's syndrome[J] Nat Genet,2013,45(11):1284-1292.
[11] CLOUGH E,BARRETT T.The gene expression omnibus database[J].Methods Mol Biol,2016,1418:93-110.
[12] 饶钰君,田龙龙,张勇斌,等.pSS患者外周血和唇腺组织中差异表达基因生物学功能分析、关键基因筛选及唇腺组织中免疫细胞变化观察[J].山东医药,2022,62(21):48-53.
[13] 赵文甲,刘维,吴沅皞.干燥综合征相关差异表达基因的筛选[J].医学研究生学报,2018,31(9):916-920.
[14] VIVINO F B,BUNYA V Y,GIACOMINA M G,et al.Sjogren's syndrome:an update on disease pathogenesis,clinical manifestations and treatment[J].Clin Immunol,2019,203:81-121.
[15] JAMES J A,HARLEY J B,SCOFIELD R H.Role of viruses in systemic lupus erythematosus and Sjogren syndrome[J].Curr Opin Rheumatol,2001,13(5):370-376.
[16] 李华,王吉波,王丽琴.干燥综合征患者EB病毒感染分析[J].中华医院感染学杂志,2014,24(24):6154-6155,6176.
[17] YAO Y,LIU Z,JALLAL B,et al.Type I interferons in sjogren's syndrome[J].Autoimmun Re,2013,12(5):558-566.
[18] BRKIC Z,MARIA N I,HELDEN-MEEUWSEN C G,et al.Prevalence of interferon type I signature in CD14 monocytes of patients with sjogren's syndrome and association with disease activity and BAFF gene expression[J].Ann Rheum Dis,2013,72(5):728-735.
[19] ZHU H,ZHENG J,ZHOU Y,et al.Knock down of RSAD2 attenuates B cell hyperactivity in patients with primary sjögren's syndrome(pSS) via suppressing NF-κb signaling pathway[J].Mol Cell Biochem,2021,476(5):2029-2037.
[20] LIU B Q,LIU R B,LI W P,et al.XAF1 prevents hyperproduction of type I interferon upon viral infection by targeting IRF7[J].EMBORep,2023,24(1):e55387.
[21] MARIA N I,BRKIC Z,WARIS M,et al.MXA as a clinically applicable biomarker for identifying systemic interferon type I in primary sjogren's syndrome[J].Ann Rheum Dis,2014,73(6):1052-1059.
[22] MARIA N I,STEENWIJK E C,IJPMA A S,et al.Contrasting expression pattern of RNA-sensing receptors TLR7,RIG-I and MDA5 in interferon-positive and interferon-negative patients with primary sjögren's syndrome[J].Ann Rheum Dis,2017,76(4):1-10.
[23] HJELMERVIK T O R,PETERSEN K,JONASSEN I,et al.Gene expression profiling of minor salivary glands clearly distinguishes primary sjögren's syndrome patients from healthy control subjects[J].Arthritis Rheum,2005,52(5):1534-1544. |